Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
27.6%
% of FMED's 65 holdings also in HRTS
41.0%
% of HRTS's 39 holdings also in FMED
Overlap by Weight
Sector Drift (FMED minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FMED |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 4.4% | 4.7% | 4.4% |
|
BOSTON SCIENTIFIC CORP | 5.6% | 3.1% | 3.1% |
|
REGENERON PHARMACEUTICALS | 3.8% | 2.4% | 2.4% |
|
ELI LILLY & CO | 2.3% | 6.4% | 2.3% |
|
INSULET CORP | 3.4% | 2.0% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
FMED Overweight Relative to HRTS
|
UNITEDHEALTH GROUP INC | 4.7% |
|
DANAHER CORP | 3.9% |
|
INTUITIVE SURGICAL INC | 3.8% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 3.0% |
 |
ARGENX SE ADR | 2.9% |
|
EXACT SCIENCES CORP | 2.6% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
|
STRYKER CORP | 2.5% |
|
UCB SA | 2.3% |
|
MERCK & CO. INC. | 2.3% |
FMED Underweight Relative to HRTS
|
AMGEN INC | -5.1% |
|
VERTEX PHARMACEUTICALS INC | -4.6% |
|
ELI LILLY & CO | -4.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
|
BRIDGEBIO PHARMA, INC. | -3.8% |
 |
NOVO NORDISK A/S-B | -3.6% |
|
CRINETICS PHARMACEUTICALS INC | -3.4% |
 |
ASTRAZENECA PLC | -3.1% |
 |
MEDTRONIC PLC | -3.0% |
|
MIRUM PHARMACEUTICALS, INC. | -2.6% |